11 Firmen mit Ergebnissen für "engl"

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

123 Ergebnisse für "engl" unter Somagenetix

ENGL. CV

... ENGL. CV Curriculum Vitae Prof. Dr. Bettina Gockel University of Zurich Institute of Art History ... ENGL. CV ... ENGL. CV Curriculum Vitae Prof. Dr. Bettina Gockel University of Zurich Institute of Art History ... ENGL. CV ...

Unfolding the Missing Aquapolis. Barragán’s Concerns with the Hydri...

... . Die vierzehn Beiträge (dt. und engl.) adressieren auf inhaltlicher und methodologischer Ebene die ... , Aneignung und Ortsspezifik in den Mittelpunkt gerückt. Die vierzehn Beiträge (dt. und engl.) adressieren auf ... Ortsspezifik in den Mittelpunkt gerückt. Die vierzehn Beiträge (dt. und engl.) adressieren auf inhaltlicher und ... vierzehn Beiträge (dt. und engl.) adressieren auf inhaltlicher und methodologischer Ebene die ...

Mehr Ergebnisse

PolyGEL Tec AG

http://www.novogel.ch  

8952 Schlieren, Wagistrasse 4

 +41 44 731 93 07

NovoGEL was founded to implement its novel key technology based on macromolecular networks into a spectrum of innovative products.

PolyGEL Tec AG

Wagistrasse 4

8952 Schlieren

1 Ergebnisse für "engl" unter PolyGEL Tec AG

Referenz Prof Suter ETHZ engl

... Referenz Prof Suter ETHZ engl 1 Translation of Prof. U.W. Suter's evaluation document for the ZKB ... Referenz Prof Suter ETHZ engl 1 Translation of Prof. U.W. Suter's evaluation document for the ZKB ... Referenz Prof Suter ETHZ engl ... Referenz Prof Suter ETHZ engl ...

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

40 Ergebnisse für "engl" unter University of Zurich

DRG Fragebogen Zwei 2014_02_24 engl clean

... DRG Fragebogen Zwei 2014_02_24 engl clean Questionnaire: Impacts of DRG-based hospital financing ... DRG Fragebogen Zwei 2014_02_24 engl clean ... - engl-clean.pdf ... DRG Fragebogen Zwei 2014_02_24 engl clean ...

Abstract (English, Feb. 2015)

... das Pflegekinderwesen vom 2. Juli 1921 [ Engl. ‘Disciplinarily he does not present any difficulties but ... das Pflegekinderwesen vom 2. Juli 1921 [ Engl. ‘Disciplinarily he does not present any difficulties but ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

35 Ergebnisse für "engl" unter ETH Entrepreneurship

Soft and Living Materials Alumni – Soft and Living Materials | ETH ...

...   Dr. Wilfried Engl Prof. Holger Kress (spring 2007 - spring 2010) - now at University of Bayreuth ... der Veen - now at IMEC, Belgium  Dr. Wilfried Engl Prof. Holger Kress (spring 2007 - spring 2010 ...

New Paper by the Piel Lab – Institute of Microbiology | ETH Zurich

... . Linington, Jörn Piel Angew Chem Int Ed Engl. 2018 Oct 26;57(44):14519-14523. doi: 10.1002/anie.201805673 ... Engl. 2018 Oct 26;57(44):14519-14523. doi: 10.1002/anie.201805673. Epub 2018 Aug 23. The large number ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

77 Ergebnisse für "engl" unter University Hospital Zurich​, Research and Education Office

... RM. N Engl J Med. 2017 Jun 8;376(23):2211-2222. Prolonged Survival in Stage III Melanoma with ... , Testori A. N Engl J Med. 2016 Nov 10;375(19):1845-1855. Overall Survival with Combined Nivolumab and ... RM. N Engl J Med. 2017 Jun 8;376(23):2211-2222. Prolonged Survival in Stage III Melanoma with ... , Testori A. N Engl J Med. 2016 Nov 10;375(19):1845-1855. Overall Survival with Combined Nivolumab and ...

... . Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis. N Engl J Med. 2019 Dec 19;381(25 ... ; PredART Trial Team. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS. N Engl J ... . Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis. N Engl J Med. 2019 Dec 19;381(25 ... ; PredART Trial Team. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS. N Engl J ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

94 Ergebnisse für "engl" unter Roche Glycart AG

Elecsys® Vitamin D total II

... -561. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281. Roche Diagnostics, Method Sheet ... . Vitamin D deficiency. N Engl J Med 2007;357:266-281. Roche Diagnostics, Method Sheet Elecsys® Vitamin D ...

Elecsys® Vitamin D total II

... Engl J Med 2007;357:266-281. Roche Diagnostics, Method Sheet Elecsys® Vitamin D total II, 2018 ONTDEK ... ." Archives of internal medicine 169.6 (2009): 551-561. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357 ...

Mehr Ergebnisse

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

33 Ergebnisse für "engl" unter Blutspende SRK Zürich

DGTI_frb_Iron Balance_07.qxp

... : Anemia of Chronic Disease. N Engl J Med, 2005: 352; 10: 1011-1023 2) R.E. Fleming and B.R. Bacon ... : Orchestration of Iron Homeostasis. N Engl J Med, 2005: 352; 17: 1741-1744 3) N.C. Andrews: Disorders of Iron ... : Anemia of Chronic Disease. N Engl J Med, 2005: 352; 10: 1011-1023 2) R.E. Fleming and B.R. Bacon ... : Orchestration of Iron Homeostasis. N Engl J Med, 2005: 352; 17: 1741-1744 3) N.C. Andrews: Disorders of Iron ...

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

... engl j med 383;27 nejm.org December 31, 2020 2603 established in 1812 December 31, 2020 vol. 383 no. 27 ... published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. N Engl J Med 2020;383:2603-15 ... engl j med 383;27 nejm.org December 31, 2020 2603 established in 1812 December 31, 2020 vol. 383 no. 27 ... published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. N Engl J Med 2020;383:2603-15 ...

Mehr Ergebnisse

SecureCell AG

http://www.securecell.ch/  

8902 Urdorf, In der Luberzen 29

 +41 44 732 91 00
 contact@securecell.ch

Securecell is pioneering the world’s next solutions for global biotech and MedTech systems. From automated bioprocessing and smart pharmacological facilities to the transformative applications of digital technologies to help hospitals and life scientists solve next-world problems. At Securecell we believe the best future should be our next future, hence our technologies represent innovative solutions that can improve lives on a global scale.

SecureCell AG

In der Luberzen 29

8902 Urdorf

3 Ergebnisse für "engl" unter SecureCell AG

Securecell

... . 1902-12. 3 Lind, M., et al., Glycemic control and excess mortality in type 1 diabetes. N Engl J Med ... control and excess mortality in type 1 diabetes. N Engl J Med, 2014. 371(21): p. 1972-82. 4 Cartwright A ...

Securecell

... control and excess mortality in type 1 diabetes. N Engl J Med, 2014. 371(21): p. 1972-82. 4 Cartwright A ... , M., et al., Glycemic control and excess mortality in type 1 diabetes. N Engl J Med, 2014. 371(21): p ...

Mehr Ergebnisse

Virometix AG

http://virometix.com  

8952 Schlieren, Wagistrasse 14

 +41 (0)43 433 86 60
 info@virometix.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

Virometix AG

Wagistrasse 14

8952 Schlieren

2 Ergebnisse für "engl" unter Virometix AG

Newsroom - Virometix AG

... is responsible for the European operations and Commercial Practice. Angew Chem Int Ed Engl. 2007;46 ... , Moehle K, Robinson JA. Angew Chem Int Ed Engl. 2007;46(47):9015-8. doi: 10.1002/anie.200702805. PMID ... , Thomas RM, Ghasparian A, Freund-Renard A, Moehle K, Robinson JA. Angew Chem Int Ed Engl.2007;46(47):9015 ...

Newsroom - Virometix AG

... ; https://doi.org/10.1038/s41541-021-00347-y Angew Chem Int Ed Engl. 2007;46(47):9015-8. doi: 10.1002/anie ... . Angew Chem Int Ed Engl. 2007;46(47):9015-8. doi: 10.1002/anie.200702805. PMID: 17935102 No abstract ... , Ghasparian A, Freund-Renard A, Moehle K, Robinson JA. Angew Chem Int Ed Engl.2007;46(47):9015-8. > PubMed ...

CSL Vifor

https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor  

8952 Schlieren, Zürcherstrasse 39D

 +41 58 851 80 00

Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.

CSL Vifor

Zürcherstrasse 39D

8952 Schlieren

2 Ergebnisse für "engl" unter CSL Vifor

Ferinject® granted upgraded recommendations in 2023 ESC heart failu...

... carboxymaltose in heart failure with iron deficiency. N Engl J Med 2023 [published on-line] DOI: 10.1056 ... carboxymaltose in heart failure with iron deficiency. N Engl J Med 2023 [published on-line] DOI: 10.1056 ...

CSLCapitalMarketsDay.pdf

... Investigators et al. Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor. N Engl J Med ... Investigators et al. Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor. N Engl J Med ...

Mehr Firmen

Nach oben